P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2
HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e214536e
10.1097/01.hs9.0000971228.21453.6e